Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GNS-212-E in Bowel Preparation for Colonoscopy
NCT06317350Phase 3Completed
- Sponsor
- Gunkang Pharmaceuticals, Inc.
- Start
- Mar 2024
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of GNS-212-E1 in bowel preparation (3 arms), sponsored by Gunkang Pharmaceuticals, Inc. Primary endpoint: Harefield Cleansing Scale. Started Mar 2024; status: completed.
02
Drugs
GNS-212-E1
03
Conditions
bowel preparation
Beyond the preview
Go deeper on NCT06317350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06317350.